These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 27529781)

  • 1. Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods.
    Moitessier N; Pottel J; Therrien E; Englebienne P; Liu Z; Tomberg A; Corbeil CR
    Acc Chem Res; 2016 Sep; 49(9):1646-57. PubMed ID: 27529781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking ligands into flexible and solvated macromolecules. 7. Impact of protein flexibility and water molecules on docking-based virtual screening accuracy.
    Therrien E; Weill N; Tomberg A; Corbeil CR; Lee D; Moitessier N
    J Chem Inf Model; 2014 Nov; 54(11):3198-210. PubMed ID: 25280064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking Ligands into Flexible and Solvated Macromolecules. 8. Forming New Bonds─Challenges and Opportunities.
    Labarre A; Stille JK; Patrascu MB; Martins A; Pottel J; Moitessier N
    J Chem Inf Model; 2022 Feb; 62(4):1061-1077. PubMed ID: 35133156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Evaluation of Covalent Docking Tools.
    Scarpino A; Ferenczy GG; Keserű GM
    J Chem Inf Model; 2018 Jul; 58(7):1441-1458. PubMed ID: 29890081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Covalent Ligands via Noncovalent Docking by Dissecting Covalent Docking Based on a "Steric-Clashes Alleviating Receptor (SCAR)" Strategy.
    Ai Y; Yu L; Tan X; Chai X; Liu S
    J Chem Inf Model; 2016 Aug; 56(8):1563-75. PubMed ID: 27411028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking ligands into flexible and solvated macromolecules. 6. Development and application to the docking of HDACs and other zinc metalloenzymes inhibitors.
    Pottel J; Therrien E; Gleason JL; Moitessier N
    J Chem Inf Model; 2014 Jan; 54(1):254-65. PubMed ID: 24364808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein structure-based drug design: from docking to molecular dynamics.
    Śledź P; Caflisch A
    Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and current status of computational methods for docking small molecules to nucleic acids.
    Luo J; Wei W; Waldispühl J; Moitessier N
    Eur J Med Chem; 2019 Apr; 168():414-425. PubMed ID: 30831409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico screening of quadruplex-binding ligands.
    Ma DL; Ma VP; Chan DS; Leung KH; Zhong HJ; Leung CH
    Methods; 2012 May; 57(1):106-14. PubMed ID: 22391485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking covalent inhibitors: a parameter free approach to pose prediction and scoring.
    Zhu K; Borrelli KW; Greenwood JR; Day T; Abel R; Farid RS; Harder E
    J Chem Inf Model; 2014 Jul; 54(7):1932-40. PubMed ID: 24916536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of automated docking programs for docking and database screening against RNA drug targets.
    Detering C; Varani G
    J Med Chem; 2004 Aug; 47(17):4188-201. PubMed ID: 15293991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics in drug design.
    Zhao H; Caflisch A
    Eur J Med Chem; 2015 Feb; 91():4-14. PubMed ID: 25108504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.
    De Cesco S; Deslandes S; Therrien E; Levan D; Cueto M; Schmidt R; Cantin LD; Mittermaier A; Juillerat-Jeanneret L; Moitessier N
    J Med Chem; 2012 Jul; 55(14):6306-15. PubMed ID: 22765237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0.
    Corbeil CR; Englebienne P; Moitessier N
    J Chem Inf Model; 2007; 47(2):435-49. PubMed ID: 17305329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
    Morency LP; Gaudreault F; Najmanovich R
    Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.